[
  {
    "ts": "2026-01-27T00:36:31+00:00",
    "headline": "Why Revolution Medicines Stock Plummeted by Almost 17% Today",
    "summary": "It doesn't look like the company will end up in the arms of an acquirer soon, after all.",
    "url": "https://www.fool.com/investing/2026/01/26/why-revolution-medicines-stock-plummeted-by-almost/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "62bcee3a-399f-331d-a7d9-534e05e193a0",
      "content": {
        "id": "62bcee3a-399f-331d-a7d9-534e05e193a0",
        "contentType": "STORY",
        "title": "Why Revolution Medicines Stock Plummeted by Almost 17% Today",
        "description": "",
        "summary": "It doesn't look like the company will end up in the arms of an acquirer soon, after all.",
        "pubDate": "2026-01-27T00:36:31Z",
        "displayTime": "2026-01-27T00:36:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/ee696e0da5c813fb1c4a5282f8ed4a46",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Healthcare professional inspecting charts.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G2Nngiu5SBti5VKT89jV7w--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/ee696e0da5c813fb1c4a5282f8ed4a46.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vWRHtc9UYu1FbuK.auZRnQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/ee696e0da5c813fb1c4a5282f8ed4a46.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/26/why-revolution-medicines-stock-plummeted-by-almost/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-revolution-medicines-stock-plummeted-003631182.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RVMD"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-27T07:14:27+00:00",
    "headline": "Merck’s (MRK) Quality is Clear, but Growth Visibility Matters, TD Cowen Notes",
    "summary": "Merck & Co., Inc. (NYSE:MRK) is included among the 15 Best S&P 500 Dividend Stocks to Buy in 2026. On January 20, TD Cowen analyst Steve Scala raised Merck & Co., Inc. (NYSE:MRK) price target to $120 from $100. The firm maintained a Hold rating. The analyst acknowledged that Merck is a strong and well-run […]",
    "url": "https://finance.yahoo.com/news/merck-mrk-quality-clear-growth-071427770.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "60228a46-143e-3761-8e6b-5b404b856da3",
      "content": {
        "id": "60228a46-143e-3761-8e6b-5b404b856da3",
        "contentType": "STORY",
        "title": "Merck’s (MRK) Quality is Clear, but Growth Visibility Matters, TD Cowen Notes",
        "description": "",
        "summary": "Merck & Co., Inc. (NYSE:MRK) is included among the 15 Best S&P 500 Dividend Stocks to Buy in 2026. On January 20, TD Cowen analyst Steve Scala raised Merck & Co., Inc. (NYSE:MRK) price target to $120 from $100. The firm maintained a Hold rating. The analyst acknowledged that Merck is a strong and well-run […]",
        "pubDate": "2026-01-27T07:14:27Z",
        "displayTime": "2026-01-27T07:14:27Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Merck’s (MRK) Quality is Clear, but Growth Visibility Matters, TD Cowen Notes",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UKiv8LHLxutAA7dDIzr_pw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1v0rnd.QZj0de1gLzaNuAg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-mrk-quality-clear-growth-071427770.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-mrk-quality-clear-growth-071427770.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-27T06:52:36+00:00",
    "headline": "Bernstein Calls 2026 a “Waiting Year” for Amgen’s (AMGN) MariTide",
    "summary": "Amgen Inc. (NASDAQ:AMGN) is included among the 15 Best S&P 500 Dividend Stocks to Buy in 2026. On January 20, Bernstein downgraded Amgen Inc. (NASDAQ:AMGN) to Market Perform from Outperform, while leaving its $335 price target unchanged. The firm said the decision was mainly driven by its view that “2026 is a waiting year” for […]",
    "url": "https://finance.yahoo.com/news/bernstein-calls-2026-waiting-amgen-065236578.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "457122a4-745e-3555-9eb2-03d11d5d2c31",
      "content": {
        "id": "457122a4-745e-3555-9eb2-03d11d5d2c31",
        "contentType": "STORY",
        "title": "Bernstein Calls 2026 a “Waiting Year” for Amgen’s (AMGN) MariTide",
        "description": "",
        "summary": "Amgen Inc. (NASDAQ:AMGN) is included among the 15 Best S&P 500 Dividend Stocks to Buy in 2026. On January 20, Bernstein downgraded Amgen Inc. (NASDAQ:AMGN) to Market Perform from Outperform, while leaving its $335 price target unchanged. The firm said the decision was mainly driven by its view that “2026 is a waiting year” for […]",
        "pubDate": "2026-01-27T06:52:36Z",
        "displayTime": "2026-01-27T06:52:36Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/51e557354b24b248245adac46ac0da45",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Bernstein Calls 2026 a “Waiting Year” for Amgen’s (AMGN) MariTide",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fl9k_iPg0JyfVI.qZJRd8A--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/51e557354b24b248245adac46ac0da45.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RgojEqpZ8ITlaPGpQimL8Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/51e557354b24b248245adac46ac0da45.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bernstein-calls-2026-waiting-amgen-065236578.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bernstein-calls-2026-waiting-amgen-065236578.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "NVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-27T10:02:35+00:00",
    "headline": "Revolution Medicines (RVMD) Dives 16.9% as Merck Withdraws Takeover Plan",
    "summary": "We recently published 10 Big Names Stumbling Hard. Revolution Medicines Inc. (NASDAQ:RVMD) was one of the worst performers on Monday. Revolution Medicines fell sharply on Monday, losing 16.91 percent to close at $97.78 apiece, as investors unloaded portfolios following news that pharmaceutical giant Merck had cancelled ongoing negotiations for its proposed acquisition of the company. […]",
    "url": "https://finance.yahoo.com/news/revolution-medicines-rvmd-dives-16-100235729.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "04741729-f2ab-340b-a669-9abe782cf479",
      "content": {
        "id": "04741729-f2ab-340b-a669-9abe782cf479",
        "contentType": "STORY",
        "title": "Revolution Medicines (RVMD) Dives 16.9% as Merck Withdraws Takeover Plan",
        "description": "",
        "summary": "We recently published 10 Big Names Stumbling Hard. Revolution Medicines Inc. (NASDAQ:RVMD) was one of the worst performers on Monday. Revolution Medicines fell sharply on Monday, losing 16.91 percent to close at $97.78 apiece, as investors unloaded portfolios following news that pharmaceutical giant Merck had cancelled ongoing negotiations for its proposed acquisition of the company. […]",
        "pubDate": "2026-01-27T10:02:35Z",
        "displayTime": "2026-01-27T10:02:35Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/bb9eeca959da429f530467dc58c79488",
          "originalWidth": 768,
          "originalHeight": 512,
          "caption": "Revolution Medicines (RVMD) Dives 16.9% as Merck Withdraws Takeover Plan",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/L6CMpFrYeopyfVnnz0zZAA--~B/aD01MTI7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/bb9eeca959da429f530467dc58c79488.cf.webp",
              "width": 768,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vVDSbH1T4crsVM0rpSIWSg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/bb9eeca959da429f530467dc58c79488.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/revolution-medicines-rvmd-dives-16-100235729.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/revolution-medicines-rvmd-dives-16-100235729.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RVMD"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]